Anxiety is a frequent comorbid illness with neurological disorders. This chapter looks at the most common anxiolytics currently used and gives guidance in their proper use. The mainstays of long-term treatment in any of the anxiety disorders are the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs). Acute treatment relies on benzodiazepines. Despite the effectiveness of the SSRIs and SNRIs, other medications are commonly used. Patient features which are prominent in the decision on which agent to use and patient features most commonly experienced in clinical practice are discussed. The nuances and rationales for various medications are reviewed. Additionally, the use of adjunctive medications is examined.
KeywordsAnxiolytics Neurological conditions Generalized anxiety disorder Panic disorder SSRIs SNRIs
- 2.Cassidy K-L, Rector NA. The silent geriatric giant: anxiety disorders in late life. Geriatr Aging. 2008;11(3):150–6.Google Scholar
- 20.American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.Google Scholar
- 26.Zung WW. A rating instrument for anxiety disorders. Psychosom J Consult Liaison Psychiatry. 1971;12:371–9.Google Scholar
- 39.Baldwin DS, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403–39.CrossRefPubMedGoogle Scholar